Ovid Therapeutics maintained at Buy by HC Wainwright
HC Wainwright & Co maintained a Buy rating on Ovid Therapeutics, per ratings actions cited.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.